Dr Ruangelie Edrada-Ebel

Senior Lecturer

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Dr Edrada-Ebel currently heads the Natural Products Metabolomics Group (NPMG) and is currently author of more than 100 publications and two patents on the topic marine natural products. She referees articles on marine natural products on more than 10 peer-reviewed journals and is a member of the editorial board for Marine Drugs. Her expertise comprises both natural products isolation and structure elucidation with modern spectroscopic techniques. At present, she has a series of on-going projects on the application of metabolomics to identify and biotechnologically optimize the production of bioactive secondary metabolites in marine-derived microorganisms.

Prizes and awards

Thieme Award 2018 for the Most Innovative Planta Medica Original Paper

More prizes and awards


Positions Held:

2015 to date Senior Lecturer in Pharmaceutical Analysis, Strathclyde Institute of Pharmacy and Biomedical Sciences

2008 to 2014 Lecturer in Pharmaceutical Analysis, Strathclyde Institute of Pharmacy and Biomedical Sciences

2007 to 2008 NMR and MS Facility Manager, Strathclyde Institute of Pharmacy and Biomedical Sciences

2005 to 2007 Research Scientist (part-time), BioMar, Düsseldorf Life Science Centre

2001 to 2007 Senior Researcher and Instructor, Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine Universität Düsseldorf

1999 to 2001 Research Fellow (Post Doctorate), Department of Chemistry, University of California Santa Cruz

1998 to 1999 Research Fellow, Department of Chemistry and Biochemistry, University of Oklahoma

1989 to 1993 Instructor, College of Pharmacy, University of the Philippines

Educational Background: 

1994 – 1998  Doctorate degree in Pharmaceutical Biology, Julius Maximillians-University of Würzburg, Germany, Magna cum Laude, Dissertation: “Isolation and structure elucidation of bioactive secondary metabolites from Philippine marine sponges and soft corals.” Adviser:  Prof. Dr. Peter Proksch, Date of Graduation: 18 June 1998

1989 - 1992  Master of Science degree in Pharmacy, University of the Philippines, Manila, Philippines,  Thesis: “The biological and chemical investigation of the colored constituents of Kokoona ochracea (Elm) Merrill (Fam. Celastraceae).”


UHPLC-(ESI)-HRMS and NMR-based metabolomics approach to access the seasonality of Byrsonima intermedia and Serjania marginata from Brazilian Cerrado flora diversity
Zanatta Ana C, Vilegas Wagner, Edrada-Ebel Ru Angelie
Frontiers in Chemistry Vol 9 (2021)
Biodiscovery of potential antibacterial diagnostic metabolites from the endolichenic fungus Xylaria venustula using LC–MS-based metabolomics
Santiago Krystle Angelique A, Edrada-Ebel RuAngelie, dela Cruz Thomas Edison E, Cheow Yuen Lin, Ting Adeline Su Yien
Biology Vol 10 (2021)
Exploring the chemical space of macro- and micro-algae using comparative metabolomics
Hughes Alison H, Magot Florent, Tawfike Ahmed F, Rad-Menéndez Cecilia, Thomas Naomi, Young Louise C, Stucchi Laura, Carettoni Daniele, Stanley Michele S, Edrada-Ebel RuAngelie, Duncan Katherine R
Microorganisms Vol 9 (2021)
Targeted isolation of anti-trypanosomal naphthofuran-quinone compounds from the mangrove plant Avicennia lanata
Mazlan Noor Wini, Clements Carol, Edrada-Ebel RuAngelie
Marine Drugs Vol 18 (2020)
Morphological, genotypic and metabolomic signatures confirm interfamilial hybridization between the ubiquitous kelps Macrocystis (Arthrothamnaceae) and Lessonia (Lessoniaceae)
Murúa Pedro, Edrada-Ebel Ru Angelie, Muñoz Liliana, Soldatou Sylvia, Legrave Nathalie, Müller Dieter G, Patiño David J, van West Pieter, Küpper Frithjof C, Westermeier Renato, Ebel Rainer, Peters Akira F
Scientific Reports Vol 10 (2020)
Metabolomic tools used in marine natural product drug discovery
Stuart Kevin Andrew, Welsh Keira, Walker Molly Clare, Edrada-Ebel RuAngelie
Expert Opinion on Drug Discovery Vol 15, pp. 499-522 (2020)

More publications

Research interests

  • Natural products metabolomics to optimise production of secondary metabolites in their microbial sources as well as using metabolomics tools in targeting the isolation of bioactive metabolites from their natural sources. Collaboration has been established with Professor Ron Quinn of the Griffith Institute for Drug Discovery, Griffith University and Professor  Fernando da Costa of the School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo.
  • Metabolomics of microbial symbionts in collaboration with Professor Ute Hentschel of the Sponge Microbiology Group at the GEOMAR Helmholtz Centre for Ocean Research Kiel and partners with SeaBioTech, an FP-7 funded project.
  • Real Time Flux Modeling in Biopharmaceutical Bioprocessing, jointly co-funded by the BBSRC and the EPSRC, a collaborative research on metabolomics and fermentation work as well as further national collaborative work with Scottish medium-scale enterprises on the cultivation of marine microorganism. 
  • Metagenomic approach of optimizing the production of novel antibiotics from Streptomyces
  • Propolis project with Beevital exploring the anti-trypanosomal activity of the African Propolis collection
  • Ecological implications of the production of secondary metabolites in Crustaeceans and alternative application of utilising the waste products of the by-catch in collaboration with the Langoustine Laboratory, University of Glasgow.
  • Dereplication study and metabolomics of sponges and their endozooic microorganism obtained from the Irish and Celtic Sea (in collaboration with Prof. Alan Dobson, Environmental Research Institute, University College Cork)
  • Structure elucidation of biologically active secondary metabolites from sponges, tropical plants, and marine-derived fungi
  • Phytochemistry of biologically active secondary metabolites from tropical plants from Southeast Asia and Africa (in collaboration with Prof. Alan Harvey, SIDR)
  • Mass spectral analysis of marine-derived synthetic pyridinium polymers as novel anti-cancer drugs (in collaboration with Prof. Marcel Jaspars, University of Aberdeen)

Professional activities

Krystle Angelique Santiago
Jake Coyle
Accelerate Chemistry Challenge Programme for Secondary Schools in Scotland: S@S Accelerate 2018: Education Challenge
Invited speaker
Euroindoamerican Natural Products Meeting
Keynote/plenary speaker

More professional activities


Discovery of New Drug Leads from Red Sea Marine Fungi
Edrada-Ebel, Ruangelie (Principal Investigator)
12-Jan-2021 - 11-Jan-2022
Development of high-value compounds from Bacillus licheniformis
Edrada-Ebel, Ruangelie (Principal Investigator) Young, Louise (Co-investigator)
01-Jan-2017 - 28-Jan-2018
Identification of pathway specific anti-cancer compounds from Scottish Marine Microbes
Edrada-Ebel, Ruangelie (Principal Investigator)
This agreement is applicable to only the original MATERIAL for the analyses of chemical contents of a series of research materials originating from Scotland.
29-Jan-2016 - 28-Jan-2018
Potential novel antibiotics from microorganisms of under explored extreme marine habitats
Edrada-Ebel, Ruangelie (Principal Investigator)
25-Jan-2016 - 24-Jan-2016
Escaping Bio-Assay Guided Isolation: Nature's Tools for Chemical Biology
Edrada-Ebel, Ruangelie (Principal Investigator)
01-Jan-2015 - 31-Jan-2018
Comparative transcriptomic and metabolomic analysis of engineered bacteria
Tucker, Nicholas (Principal Investigator) Edrada-Ebel, Ruangelie (Co-investigator)
Analysis of industrial biotech strains produced by Ingenza
18-Jan-2014 - 18-Jan-2015

More projects


Strathclyde Institute of Pharmacy and Biomedical Sciences
Hamnett Wing

Location Map

View University of Strathclyde in a larger map